Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates

Research output: Contribution to journalJournal articleResearchpeer-review

  • Marnix Lameijer
  • Tina Binderup
  • Mandy M. T. Van Leent
  • Max L. Senders
  • Francois Fay
  • Joost Malkus
  • Brenda L. Sanchez-gaytan
  • Abraham J. P. Teunissen
  • Nicolas Karakatsanis
  • Philip Robson
  • Xianxiao Zhou
  • Yuxiang Ye
  • Gregory Wojtkiewicz
  • Jun Tang
  • Tom T. P. Seijkens
  • Jeffrey Kroon
  • Erik S. G. Stroes
  • Jordi Ochando
  • Thomas Reiner
  • Carlos Pérez-medina
  • Claudia Calcagno
  • Edward A. Fisher
  • Bin Zhang
  • Ryan E. Temel
  • Filip K. Swirski
  • Matthias Nahrendorf
  • Zahi A. Fayad
  • Esther Lutgens
  • Willem J. M. Mulder
  • Raphaël Duivenvoorden
Original languageEnglish
JournalNature Biomedical Engineering
Volume2
Pages (from-to)279-292
DOIs
Publication statusPublished - 2018

ID: 216468062